Abstract
Objective:
To investigate the influence of different pre- and probiotics on faecal β-glucuronidase and β-glucosidase activity, as one of the claimed beneficial effects of pre- and probiotics is the hypothesis that these substrates are able to reduce the production of toxic and carcinogenic metabolites by suppressing specific enzyme activities in the colon.
Setting:
Department of Gastrointestinal Research, University Hospital Gasthuisberg, KU Leuven, Belgium.
Design and subjects:
The effect was evaluated in a randomized, crossover study in 53 healthy volunteers who were randomly assigned to one of five treatment groups.
Interventions:
At the start and after a 4-week treatment period, the healthy volunteers collected faeces during 72 h. Lactulose and oligofructose-enriched inulin (OF-IN) were chosen as prebiotics, whereas Lactobacillus casei Shirota, Bifidobacterium breve and Saccharomyces boulardii were selected as probiotics. Two synbiotic combinations were evaluated as well. The enzyme activity was assessed spectrophotometricly.
Results:
Lactulose and OF-IN significantly decreased β-glucuronidase activity, whereas a tendency to a decreased β-glucuronidase activity was observed after L. casei Shirota and B. breve intake. To the contrary, B. breve increased β-glucosidase levels. Supplementation with the synbiotic did not appear to be more beneficial than either compound alone. No influence of S. boulardii was noted.
Conclusions:
Administration of lactulose, OF-IN, L. casei Shirota or B. breve resulted in a decrease of the β-glucuronidase activity, which is considered beneficial for the host.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs
Scientific Reports Open Access 16 September 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ballongue J, Schumann C, Quignon P (1997). Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 222, 41–44.
Bauer HG, Asp N-G, Oste R, Dahlqvist A, Fredlund PE (1979). Effect of dietary fibre on the induction of colorectal tumours and fecal β-glucuronidase activity in rat. Cancer Res 39, 3752–3756.
Bingham SA (1999). High meat diets and cancer risk. Proc Nutr Soc 58, 243–248.
Bouhnik Y, Attar A, Joly FA, Riottot M, Dyard F, Flourié B (2004). Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin Nutr 58, 462–466.
Bouhnik Y, Flourie B, Andrieux C, Bisetti N, Briet F, Rambaud JC (1996). Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur J Clin Nutr 50, 269–273.
Buddington RK, Williams CH, Chen SC, Witherly SA (1996). Dietary supplement of neosugar alters the faecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63, 709–716.
De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K (2006). Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharm Ther 23, 963–974.
Fioramonti J, Theodorou V, Bueno L (2003). Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 17, 711–724.
Goldin BR, Gorbach SL (1976). The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 57, 371–375.
Goldin BR, Gorbach SL (1984). The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39, 756–761.
Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL (1980). Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 64, 255–261.
Goldin BR (1990). Intestinal microflora: metabolism of drugs and carcinogens. Ann Med 22, 43–48.
Goossens D, Jonkers D, Russel M, Stobberingh E, Van den Bogaard A, Stockbrügger R (2003). The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18, 495–505.
Guerin-Danan C, Chabanet C, Pedone C, Popot F, Vaissade P, Bouley C et al. (1998). Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 67, 111–117.
Haberer P, du Toit M, Dicks LMT, Ahrens F, Holzapfel WH (2003). Effect of potentially probiotic lactobacilli on faecal enzyme activity in minipigs on a high-fat, high-cholesterol diet – a preliminary in vivo trial. Int J Food Microbiol 87, 287–291.
Heavey PM, McKenna D, Rowland IR (2004). Colorectal cancer and the relationship between genes and the environment. Nutr Cancer 48, 124–141.
Hughes R, Rowland IR (2001). Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22, 43–47.
Jenkins DJA, Kendall CWC, Vuksan V (1999). Inulin, oligofructose and intestinal function. J Nutr 129, 1431S–1433S.
Lidbeck A, Overvik E, Rafter J, Nord CE, Gustafsson J-A (1992). Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans. Microbial Ecol Health Disease 5, 59–67.
Ling WH, Korpela R, Mykkänen H, Salminen S, Hänninen O (1994). Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 124, 18–23.
Mallett AK, Rowland IR, Farthing MJG (1987). Dietary modification of intestinal bacterial enzyme activities – potential formation of toxic agents in the gut. Scand J Gastroenterol 129, 251–257.
Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF et al. (1990). Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52, 685–688.
Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J (2001). Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73, 430S–436S.
Moore WE, Moore LH (1995). Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Micorbiol 61, 3202–3207.
Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, Benno Y (2002). Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol 46, 487–490.
Pool-Zobel BL, Bertram B, Knoll M, Lambertz R, Neudecker C, Schillinger U et al. (1993). Antigenotixic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr Cancer 20, 271–282.
Roberfroid MB (1999). Concepts in functional foods: the case of inulin and oligofructose. J Nutr 129, 1398S–1401S.
Roberfroid MB (2005). Introducing inulin-type fructans. Br J Nutr 93, S13–S25.
Roberfroid MB, Van Loo J, Gibson GR (1998). The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128, 11–19.
Rowland IR, Mallett AK, Wise A (1985). The effect of diet on the mammalian gut flora and its metabolic activities. Crit Rev Toxicol 16, 31–103.
Rowland IR, Tanaka R (1993). The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microbiota. J Appl Bacteriol 74, 667–674.
Schneeman BO (1999). Fiber, inulin and oligofructose: similarities and differences. J Nutr 129, 1424S–1427S.
Schumann C (2002). Medical, nutritional and technological properties of lactulose. An update. Eur J Nutr 41, 117–125.
Spanhaak S, Havenaar R, Schaafsma G (1998). The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52, 899–907.
Stephen AM, Cummings JH (1980). Mechanisms of dietary action of fibre in the human colon. Nature 284, 283–284.
Takada H, Hirooka T, Hiramatsu Y, Yamamoto M (1982). Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res 42, 331–334.
Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK (2000). Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66, 2578–2588.
Van Dokkum W, Wezendonk B, Srikumar TS, Van den Heuvel EGHM (1999). Effect of nondigestible oligosaccharides on large bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53, 1–7.
Acknowledgements
This work was supported by IWT-Vlaanderen, Brussels, Belgium (GBOU project no. 010054), the Fund for Scientific Research-Flanders, the University Research Councils and several companies. L De Vuyst, G Huys, J Swings and B Pot are acknowledged for providing scientific comments.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: K Verbeke.
Contributors: VDP helped to develop and design the study, collect and analyse the data and write the paper. (This work formed part of her doctoral dissertation.) HR, LC and EH contributed to analysis and interpretation of data. PR critically revised the paper. KV was the principal investigator and was responsible for the study design, development, and oversight and helped to prepare the paper.
Rights and permissions
About this article
Cite this article
De Preter, V., Raemen, H., Cloetens, L. et al. Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 62, 225–231 (2008). https://doi.org/10.1038/sj.ejcn.1602706
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602706
Keywords
- prebiotics
- probiotics
- β-glucuronidase
- β-glucosidase
This article is cited by
-
Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model
Applied Microbiology and Biotechnology (2020)
-
Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs
Scientific Reports (2019)
-
Evaluation of enterococci for potential probiotic utilization in dogs
Folia Microbiologica (2019)
-
A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action
World Journal of Microbiology and Biotechnology (2014)
-
Fecal Biomarkers for Research on Dietary and Lifestyle Risk Factors in Colorectal Cancer Etiology
Current Colorectal Cancer Reports (2014)